NCT03671161View on ClinicalTrials.gov

Flash Glucose Measure System and Continuous Subcutaneous Insulin Infusion Therapy in Poorly Controlled Diabetes Type 1 Patients

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

July 1, 2017

Study Completion Date

July 1, 2017

Conditions

Glucose Metabolism Disorders (Including Diabetes Mellitus)Diabetes Mellitus, Type 1

Interventions

DEVICE

Insulin Pump and flash glucose monitoring

Adults with type 1 diabetes, HbA1c \>9% (75 mmol/mol), multi daily insulin injections ( MDI) and who perform less than 2 SMBG /day. Patients will be switched to insulin pump and start a FGM system (Free Style Libre®) during 6 months.

Trial Locations (1)

75013

Groupe Hospitalier Pitié-Salpêtrière, Paris

All Listed Sponsors

lead

Groupe Hospitalier Pitie-Salpetriere

OTHER

NCT03671161 - Flash Glucose Measure System and Continuous Subcutaneous Insulin Infusion Therapy in Poorly Controlled Diabetes Type 1 Patients | Biotech Hunter | Biotech Hunter